Literature DB >> 11519038

Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion.

H Hiroumi1, H Dosaka-Akita, K Yoshida, M Shindoh, T Ohbuchi, K Fujinaga, M Nishimura.   

Abstract

Cell invasion and metastasis characterize the malignant potential of non-small-cell lung cancers (NSCLCs). We have previously reported that E1AF, a member of the Ets-related transcription factor family, confers invasive phenotype on breast cancer and oral squamous-cell carcinoma cell lines. In our study, we analyzed the E1AF expression in cell lines and resected tumors of NSCLCs by Northern blot and in situ hybridization analyses and found that 15 of 17 cell lines and 12 of 19 tumors expressed E1AF mRNA while normal lung tissue and concomitant normal cells within tumors did not. To examine the biologic importance of E1AF in NSCLCs, we introduced the E1AF gene into VMRC-LCD and NCI-H226, NSCLC cell lines lacking E1AF expression, and examined cell motility and invasion activities. E1AF-transfected VMRC-LCD cells showed increased cell motility that was 2-fold that of parental and vector-transfected control cells (p < 0.01), and both cell motility and invasion were increased 1.6-fold in NCI-H226 (p < 0.01). Furthermore, hepatocyte growth factor (HGF), which is one of the most effective cell-scattering factors, stimulated the motile and invasive activities in E1AF-transfected VMRC-LCD and NCI-H226 cells but not in their parental or vector-transfected control cells. Ets-1 mRNA expression was found in E1AF-transfected VMRC-LCD cells but not in parental or vector-transfected cells. HGF further induced expression of the Ets-1 and urokinase-type plasminogen activator (uPA) genes specifically in E1AF-transfected cells. These findings suggest that E1AF plays a substantial role in the cell motility and invasion of NSCLCs. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519038     DOI: 10.1002/ijc.1410

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

Authors:  Peter C Hollenhorst; David A Jones; Barbara J Graves
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

Review 2.  ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta       Date:  2012-03-08

3.  The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.

Authors:  Hiu-Fung Yuen; Cian M McCrudden; Ka-Kui Chan; Yuen-Piu Chan; Michelle Lok-Yee Wong; Kelvin Yuen-Kwong Chan; Ui-Soon Khoo; Simon Law; Gopesh Srivastava; Terence R Lappin; Kwok-Wah Chan; Mohamed El-Tanani
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

4.  Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.

Authors:  Zhao-Zhong Su; Devanand Sarkar; Luni Emdad; Gregory J Duigou; Charles S H Young; Joy Ware; Aaron Randolph; Kristoffer Valerie; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

5.  DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.

Authors:  Melissa Grageda; Patricia Silveyra; Neal J Thomas; Susan L DiAngelo; Joanna Floros
Journal:  Exp Lung Res       Date:  2014-12-16       Impact factor: 2.459

6.  The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.

Authors:  Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar B Kristensen; Reuven Reich; Juri Kopolovic
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines.

Authors:  Karin A Sloan; Hector A Marquez; Jun Li; Yuxia Cao; Anne Hinds; Carl J O'Hara; Satinder Kathuria; Maria I Ramirez; Mary C Williams; Hasmeena Kathuria
Journal:  Carcinogenesis       Date:  2009-05-29       Impact factor: 4.944

8.  PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.

Authors:  Zoulika Kherrouche; Didier Monte; Elisabeth Werkmeister; Luc Stoven; Yvan De Launoit; Alexis B Cortot; David Tulasne; Anne Chotteau-Lelievre
Journal:  Mol Oncol       Date:  2015-07-15       Impact factor: 6.603

9.  Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.

Authors:  Elvira L Liclican; Tonya C Walser; Saswati Hazra; Kostyantyn Krysan; Stacy J Park; Paul C Pagano; Brian K Gardner; Jill E Larsen; John D Minna; Steven M Dubinett
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-09

10.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.